Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 11/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Mercaptobenzothiazole SCHEMBL408087 | 1.00 | PSMB8 (1.00) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL5934103 | 0.98 | PSMB8 (0.95) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL4268289 | 0.98 | PSMB8 (0.95) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL8749352 | 0.98 | PSMB8 (0.95) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL29729650 | 0.98 | PSMB8 (0.95) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL19514730 | 0.88 | PSMB8 (0.78) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL5933560 | 0.85 | PSMB8 (0.72) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| 2-Mercaptobenzothiazole SCHEMBL10897718 | 0.81 | PSMB8 (0.66) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| SCHEMBL10520003 | 0.78 | PSMB8 (0.63) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 | |
| SCHEMBL18791144 | 0.74 | PSMB8 (0.61) | PSMB8ALDH1A1KDM4EHPGDCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035573-A1 | SEALANTS FOR INHIBITING CORROSION | BOEING CO (US) | 2026-02-05 | — | — | US | claimed |
| US-12297597-B2 | Cellulose composition | KEMIRA OYJ (FI) | 2025-05-13 | — | — | US | claimed |
| CN-115947678-B | Synthesis method of stable isotope 2H (D) marked 25-hydroxy vitamin D2 | 成都诺森医学检验有限公司 | 2024-01-16 | — | — | CN | claimed |
| EP-3247751-B1 | ANTICORROSION COMPOSITION AND PROCESS FOR PREPARING AN ATICORROSION LAYER ON A SURFACE OF A SUBSTRATE USING SAID COMPOSITION | SOCOMORE (FR) | 2022-10-19 | — | — | EP | claimed |
| US-20260035573-A1 | SEALANTS FOR INHIBITING CORROSION | BOEING CO (US) | 2026-02-05 | — | — | US | disclosed |
| US-12522735-B2 | Polymeric agents and compositions for inhibiting corrosion | THE BOEING COMPANY (US) | 2026-01-13 | — | — | US | disclosed |
| US-12441894-B2 | Compositions for inhibiting corrosion | THE BOEING COMPANY (US) | 2025-10-14 | — | — | US | disclosed |
| US-12297597-B2 | Cellulose composition | KEMIRA OYJ (FI) | 2025-05-13 | — | — | US | disclosed |
| EP-4527912-A1 | GREASE COMPOSITION FOR CONSTANT-VELOCITY JOINT AND CONSTANT-VELOCITY JOINT HERMETICALLY FILLED THEREWITH | Kyodo Yushi Co., Ltd. (JP) | 2025-03-26 | — | — | EP | disclosed |
| US-12163054-B2 | Soluble corrosion resistant sol-gel | THE BOEING COMPANY (US) | 2024-12-10 | — | — | US | disclosed |
| WO-2024248035-A1 | GREASE COMPOSITION | 協同油脂株式会社 | 2024-12-05 | — | — | WO | disclosed |
| WO-2024248035-A1 | GREASE COMPOSITION | 協同油脂株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-20230094130-A1 | POLYMERIC AGENTS AND COMPOSITIONS FOR INHIBITING CORROSION | THE BOEING COMPANY | 2023-03-30 | — | — | US | disclosed |
| WO-2023023298-A1 | HALLUCINOGENIC AND NON-HALLUCINOGENIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | PSILOSTERICS, LLC (US) | 2023-02-23 | — | — | WO | disclosed |
| US-11560483-B2 | Compositions for inhibiting corrosion | THE BOEING COMPANY (US) | 2023-01-24 | — | — | US | disclosed |
| CN-115521325-A | Boronic acid derivatives | 首药控股(北京)股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-115010915-A | Nitrogen branched nine-arm polyethylene glycol derivative, preparation method and biological related substance modified by nitrogen branched nine-arm polyethylene glycol derivative | 厦门赛诺邦格生物科技股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
| US-20220244263-A1 | METHODS FOR TREATING SMALL CELL NEUROENDOCRINE AND RELATED CANCERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-04 | — | — | US | disclosed |
| EP-4011367-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 | Dompe' Farmaceutici S.P.A. (IT) | 2022-06-15 | — | — | EP | disclosed |
| US-11261336-B2 | Process for applying a metal-organic framework-containing corrosion resistant coating to a substrate | THE BOEING COMPANY (US) | 2022-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035573-A1 | SEALANTS FOR INHIBITING CORROSION | EPCAM, SFRP1, FZD7 | PSMB8 1857/4885ALDH1A1 2774/4885KDM4E 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.